Biological factors that impinge on Chagas disease drug development.

about

Phenotypic screening approaches for Chagas disease drug discovery.Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas Disease

P2860

Q49862753-09975C65-F957-45B0-A3F0-D54C0EDFAAA6 Q58701155-CAB609A0-21B7-455A-AB61-657F7C6CCD97

P2860

Biological factors that impinge on Chagas disease drug development.

Item

http://www.wikidata.org/entity/Q39010376

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Biological factors that impinge on Chagas disease drug development.

@en

Biological factors that impinge on Chagas disease drug development.

@nl

type

Item

label

Biological factors that impinge on Chagas disease drug development.

@en

Biological factors that impinge on Chagas disease drug development.

@nl

prefLabel

Biological factors that impinge on Chagas disease drug development.

@en

Biological factors that impinge on Chagas disease drug development.

@nl

P1476

Biological factors that impinge on Chagas disease drug development.

@en

P2093

Amanda F Francisco

http://www.w3.org/2001/XMLSchema#string

John M Kelly

http://www.w3.org/2001/XMLSchema#string

Michael D Lewis

http://www.w3.org/2001/XMLSchema#string

Shiromani Jayawardhana

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection

Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection

A new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imaging

CD8+ T cells in Trypanosoma cruzi infection

Shotgun sequencing analysis of Trypanosoma cruzi I Sylvio X10/1 and comparison with T. cruzi VI CL Brener

The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence

Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease

Pathogenesis of chagas' disease: parasite persistence and autoimmunity

Nucleotide sequences provide evidence of genetic exchange among distantly related lineages of Trypanosoma cruzi

Mexican Trypanosoma cruzi T. cruzi I strains with different degrees of virulence induce diverse humoral and cellular immune responses in a murine experimental infection model.

P304

1871-1880

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1017/S0031182017001469

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

144

http://www.w3.org/2001/XMLSchema#string

P50

Martin C Taylor

P5008

ScienceSource

P577

2017-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28831944

http://www.w3.org/2001/XMLSchema#string

P921

Chagas disease

biomedical investigative technique

P932

5729846

http://www.w3.org/2001/XMLSchema#string

Biological factors that impinge on Chagas disease drug development.

about

P2860

P2860

Biological factors that impinge on Chagas disease drug development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932